Cited by 120Fatty Acid Research and HealthTreatment of Major DepressionTryptophan and brain disorders

The role of lipid biomarkers in major depression

Open access
Parekh, Amy, Smeeth, Demelza, Milner, Yasmin, Thuret, Sandrine·2017·Healthcare

Abstract

In the UK, the lifetime-documented prevalence of major depressive disorder (MDD) is currently 10%. Despite its increasing prevalence and devastating impact on quality of life, the pathophysiological mechanisms underpinning MDD remain to be fully elucidated. Current theories of neurobiological components remain incomplete and protein-centric, rendering pharmacological treatment options suboptimal. In this review, we highlight the pivotal role of lipids in intra- and inter-neuronal functioning, emphasising the potential use of lipids as biomarkers for MDD. The latter has significant implications for improving our understanding of MDD at the cellular and circuit level. There is particular focus on cholesterol (high and low density lipoprotein), omega-3, and omega-6 polyunsaturated fatty acids due to established evidence in the literature of a link between atherosclerotic disease and major depression. We argue that there is significant potential scope for the use of such peripheral biomarkers in the diagnosis, stratification and treatment of MDD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/healthcare5010005

Cites

157 of 157 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [38]De Freitas J.A. Lima L.M. Ranieri J.L. Olivieri J.C. Fragoso H.J. Chinzon D. Evaluation of efficacy, safety and tolerability rabeprazole in treatment of acid-peptic diseases Arq. Gastroenterol. 2002 39 60 65 12184168

Cited by

Sorted by citations

Authors
Parekh, A., Smeeth, D., Milner, Y., & Thuret, S.
Affiliations
King's College London (GB)
Corresponding author
Thuret, Sandrine
Venue
Healthcare
Publisher
MDPI AG
Published
2017-02-03
Volume
5
Issue
1
Pages
5
ISSN
2227-9032 (ISSN-L)
OpenAlex
W2585030762
Cited by
120
References
157
Citations by year
2026: 4 · 2025: 14 · 2024: 17 · 2023: 14 · 2022: 18 · 2021: 18 · 2020: 13 · 2019: 7 · 2018: 10 · 2017: 5
FWCI
0.98
Type
journal article
Language
en
Open access
Locations
  • Healthcare (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by)
Funders
Guy's and St Thomas' Charity
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
major depressive disorder, lipid biomarkers, cholesterol, high-density lipoprotein, low-density lipoprotein, omega-3 polyunsaturated fatty acids, omega-6 fatty acids, atherosclerosis, peripheral biomarkers, depression diagnosis, treatment stratification, neurobiology of depression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review